24/09/2002

UCF prepares for Breast Cancer awareness month

The Ulster Cancer Foundation (UCF) has urged women to be breast aware throughout their adult lives.

The province’s longest-established cancer charity launched the appeal in Belfast today in the run up to Breast Cancer Awareness Month, which is in October.

UCF chief executive Arlene Spiers said that women in their 50s were most at risk from the disease, but she added: “While the incidence of breast cancer rises steeply in women from their mid-30s onwards, some as young as in their 20s will also get the disease.

"It is vital that all women should check their breasts from a much younger age. In most cases lumps will be non-malignant, but in some cases they could be indicators of breast cancer.”

The conference was attended by Belfast City Hospital’s Professor Roy Spence, one of the province’s leading breast cancer surgeons, and Dr Anna Gavin, director of the Northern Ireland Cancer Registry. Along with breast cancer patients at the event were Upper Sixth form girls from two leading Belfast schools, there to hear the message first hand and to lend their support to the campaign.

The incidence of breast cancer in Northern Ireland has risen significantly in recent years to the current figure of around 900-a-year because of increased detection through the National Breast Cancer Screening Programme.

However the number of deaths has decreased because of this increased screening and improved treatments. Survival rates have also improved.

In 1993, the number of deaths was 328, but the most recent figures show a consistent decrease – 1998, 299; 1999, 290; 2000, 281.

Dr Gavin said: “Even though the incidence of breast cancer remains high, the battle against the disease is slowly being won. The number of women living full lives for many years after diagnosis has risen in the last decade due to greater understanding of the causes of the disease and more effective forms of treatment.”

This October will mark the 11th year of the Pink Ribbon appeal, which symbolises Breast Cancer Awareness Month.

Launching an appeal for £250,000, Arlene Spiers said the money was needed to enable the UCF to continue funding its research programmes and to expand its care services.

She said: “Breast cancer is an important element in this research work and it is vital that it should continue, so that we can achieve a further decrease in the number of deaths."

(GMcG)

Related Northern Ireland News Stories
Click here for the latest headlines.

05 December 2013
NI Highest Breast Cancer Survival In UK
Northern Ireland has the highest breast cancer survival rates in the UK and Ireland, according to research by Queen's University. The data for Northern Ireland was provided by the Queen’s Northern Ireland Cancer Registry to the EUROCARE 5 study. The research is part of a European-wide study into cancer survival rates.
10 October 2011
Pink Lady Backs NI Cancer Research
A Saintfield woman, Noleen Adair, who knows about cancer, having discovered she had breast cancer at 22 to be faced with radical surgery and chemotherapy has been fundraising. Noleen refuses to put her life on hold and now, the charity she founded to help others facing breast cancer has presented a dazzling £50,000 to Friends of The Cancer Centre.
06 November 2003
Belfast women attend cancer awareness meeting
Women from community groups across Belfast attended a Cancer Awareness meeting today to discuss the effect of cancer in their communities and the importance of taking up invitations for Cervical and Breast Screening.
09 September 2011
Yellowhammer Portraits Are Framing Success
Two local cancer charities, the Ulster Cancer Foundation (UCF) and Friends of the Cancer Centre, have announced a unique fundraising initiative - the opportunity to buy a highly collectable piece of art by acclaimed Irish artist, Nicola Russell, while making a significant contribution to the work of both charities.
08 August 2003
UCF calls for clearer guidelines for HRT
The Ulster Cancer Foundation has called for clearer guidelines on the use of hormone replacement therapy (HRT) following a report that some kinds of (HRT) have a signicantly greater risk of breast cancer than others.